fig2

Cordycepin alleviates oxaliplatin-induced fatty liver disease

Figure 2. Pathological Changes in the Non-Tumor Liver Tissues of 91 Patients Undergoing OCG. (A) Grading of hepatitis necrosis severity; (B) Staging of hepatic fibrosis; (C) Classification of hepatic steatosis. OCG: Oxaliplatin-based chemotherapy group; G: grade of hepatic inflammation (G0-G2); S: stage of hepatic fibrosis (S0-S4); F: grade of hepatic steatosis (F0-F3); n: number of patients.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/